WATERTOWN, Mass., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Exergen Corporation recently alleged infringement of United States Patent Nos. 6,292,685 and 7,787,938 against Advanced Diagnostics Corporation (ADC), supplier of the Adtemp 428 Non Contact Infrared Thermometer. ADC subsequently voluntarily withdrew the product from the market.
This continues Exergen's long-standing policy of policing its intellectual property, and serving notice to potential competitors that they must develop their own technology for non-invasive thermometry without employing Exergen's patented technology.
The company, recognized as a world leader in medical and industrial non-invasive temperature technologies has been developing and patenting its non-invasive thermometer technology for three decades. Exergen's Founder and CEO Francesco Pompei, Ph.D., also a Harvard research scientist, is the inventor of over 60 issued United States patents. "Accurate temperature is important at all levels of healthcare," says Dr. Pompei, "and providing the necessary accuracy non-invasively is scientifically challenging, which our patented technology has successfully accomplished," Dr. Pompei adds, "Asserting our patents not only protects our technology, but also protects users who may be expecting the accuracy of an Exergen product, from cheaper non-US made devices that have copied some of our technology."
Exergen's patented award-winning TemporalScanner™ temporal artery thermometers are US-made, used in more than half of hospitals and millions of homes, with retail models being sold in Wal-Mart, Target, Walgreens, Costco, Sam's Club, Rite Aid, Kroger, Babies R US and Toys R Us. Temporal artery thermometry is rated as the No. 1 preferred thermometry method by pediatricians according to a Pragmatic Research survey, and Exergen is the No. 1 retail thermometer brand according to Nielsen and IRI data. Accuracy in all age groups from newborns to geriatrics and all clinical settings is supported by more than 40 peer-reviewed published studies. www.exergen.com
The Exergen Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10660
CONTACT: Kimberly Ciocon Rosica Public Relations Kimberly@rosica.com P: 201.843.5600 F: 201.843.5680 95 Route 17 South, Suite 202 Paramus, New Jersey 07652